Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

3-((((3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl)methyl)amino)pentanedioic acid MeSH Supplementary Concept Data 2025


MeSH Supplementary
3-((((3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl)methyl)amino)pentanedioic acid
Unique ID
C583160
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C583160
Entry Term(s)
GSK2330672
Registry Numbers
0
Heading Mapped to
*Methylamines
*Thiazepines
Frequency
11
Note
for treatment of type 2 diabetes; structure in first source
Source
J Med Chem. 2013 Jun 27;56(12):5094-114
Date of Entry
2013/08/30
Revision Date
2013/09/03
3-((((3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl)methyl)amino)pentanedioic acid Preferred
GSK2330672 Narrower
page delivered in 0.005s